期刊文献+

Lp-PLA2联合Gensini积分对老年AMI病人PCI术后住院期间MACE的预测价值 被引量:2

下载PDF
导出
摘要 目的探讨脂蛋白相关磷脂酶A2(Lp-PLA2)联合Gensini积分对老年急性心肌梗死(AMI)病人经皮冠状动脉介入治疗(PCI)术后住院期间主要不良心血管事件(MACE)的预测价值。方法选取2017年01月—2019年12月沧州市人民医院心内科收治的行PCI的老年AMI病人215例,根据住院期间MACE发生情况,分为MACE组(68例)和非MACE组(147例);采用受试者工作特征(ROC)曲线确定Lp-PLA2判断MACE预后临界值,将病人分为高Lp-PLA2组(72例)和低Lp-PLA2组(143例)。收集病人一般临床资料及血清学相关指标,根据冠状动脉病变部位和病变程度计算Gensini积分,进行Logisitic回归分析影响MACE的高危因素。结果MACE组病人Lp-PLA2、低密度脂蛋白胆固醇(LDL-C)及Gensini积分均明显高于非MACE组;高密度脂蛋白胆固醇(HDL-C)明显低于非MACE组(P<0.05);Lp-PLA2和Gensini积分预测PCI术后MACE的曲线下面积为0.866[95%CI(0.794,0.938),P<0.05)]和0.819[95%CI(0.734,0.904),P<0.05)],二者联合曲线下面积为0.919[95%CI(0.863,0.975),P<0.05)];Lp-PLA2与Gensini积分呈正相关(r=0.8501,P<0.05)。高Lp-PLA2组比低Lp-PLA2组MACE发生率明显升高(P<0.05);多因素Logistic回归分析结果显示,术前高LpPLA2[OR=1.026,95%CI(1.008,1.043),P=0.003]、Gensini积分[OR=1.067,95%CI(1.001,1.138),P=0.048]是老年AMI病人PCI术后住院期间发生MACE的危险因素。结论Lp-PLA2水平与冠状动脉病变程度呈正相关;随着血清Lp-PLA2水平升高MACE发生率升高;术前高Lp-PLA2和Gensini积分对老年AMI病人PCI术后MACE风险有预测价值,二者联合预测价值更高。
机构地区 沧州市人民医院
出处 《中西医结合心脑血管病杂志》 2022年第15期2787-2790,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 河北省医学科学研究课题计划(No.20211161)。
  • 相关文献

参考文献5

二级参考文献43

  • 1张坚,满青青,王春荣,李红,由悦,翟屹,李莹,赵文华.中国18岁及以上人群血脂水平及分布特征[J].中华预防医学杂志,2005,39(5):302-305. 被引量:112
  • 2姚崇华,胡以松,翟凤英,杨晓光,孔灵芝,中国居民营养与健康状况调查技术执行组.我国2002年代谢综合征的流行情况[J].中国糖尿病杂志,2007,15(6):332-335. 被引量:135
  • 3Jneid H, Fonarow GC, Cannon CP, et al. Sex differences in medical care and early death after acute myocardial infarction [ J ]. Circulation, 2008, 118 (25) :2803-2810.
  • 4Jackson EA, Moscucci M, Smith DE, et al. The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) [ J ]. Am Heart J, 2011, 161(1) :106-112.
  • 5Dey S, Flather MD, Devlin G, et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events[ J]. Heart, 2009, 95 ( 1 ) :20-26.
  • 6Velders MA, Boden H, van Boven A J, et al. Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction[J]. Am J Cardiol, 2013, 111 (3) :312-318.
  • 7Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase 1: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge [ J ]. Circulation, 1987, 76 ( 1 ) : 142-154.
  • 8Zaman MJ, Stirling S, Shepstone L, et al. The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: a cohort study of the myocardial ischaemia national audit project (MINAP) [ J ]. Eur Heart J, 2014, 35(23) :1551-1558.
  • 9Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines [ J ]. J Am Coil Cardiol, 2013, 62(16) :e147-e239.
  • 10Newell MC, Henry JT, Henry TD, et al. Impact of age on treatment and outcomes in ST-elevation myocardial infarction[ J ]. Am Heart J, 2011, 161(4) :664-672.

共引文献3473

同被引文献38

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部